Skip to main content
. 2013 Sep 28;71(7):1211–1224. doi: 10.1007/s00018-013-1463-5

Fig. 1.

Fig. 1

Genetic manipulation of the TCR, showing two different methods of genetic manipulation of the therapeutic cell: recombinant T-cell receptor (rTCR) transference and chimeric antigen receptors (CAR) cloning (a). This new genetic engineering methodology consists on the redirection of the T cell antigenic specificity by the introduction of CARs using viral vectors (b) or TCR genes (variable α- and β-chains) (c)